Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Fontana

Showing results (1-10 of 183) with videos related to

Pageof 19
Sort By:
Revue Medicale Suisse|April 8, 2015
[Last generation anti-thrombotic drugs and cerebral hemorrhage ]Pierre Fontana
Revue Medicale Suisse|March 11, 2009
[The new antithrombotics in 2009]Pierre Fontana, Henri Bounameaux
Swiss Medical Weekly|December 7, 2016
Authors' reply to the technical comment from Joelle Michaud and Goranka TanackovicMarc Blondon, Pierre Fontana
Swiss Medical Weekly|July 17, 2019
Authors' reply to the technical comment from Joelle Michaud and Goranka TanackovicMarc Blondon, Pierre Fontana
Polskie Archiwum Medycyny Wewnetrznej|November 6, 2012
Aspirin for venous thromboembolism prevention and treatment: a renewal?Henri Bounameaux, Pierre Fontana
JACC. Cardiovascular Interventions|September 21, 2019
Platelet Function Testing or Genotyping: Which Should We Trust?Pierre Fontana, Jean-Luc Reny
Revue Medicale Suisse|April 5, 2008
[Frequently asked questions on clopidogrel treatment: indications, resistance, and biological evaluation in vascular patients]Pierre Fontana, Jean-Luc Reny
Archives of Internal Medicine|March 12, 2008
Laboratory-defined aspirin resistance and recurrent cardiovascular eventsPierre Fontana, Jean-Luc Reny
Expert Opinion on Pharmacotherapy|December 16, 2014
Antiplatelet drugs and platelet reactivity: is it time to halt clinical research on tailored strategies?Jean-Luc Reny, Pierre Fontana
Revue Medicale Suisse|December 6, 2018
[Antithrombotic treatments and inherited bleeding disorders]ALessandro Casini, Pierre Fontana, Thomas Lecompte
Pageof 19

Showing results (1-10 of 183) with videos related to

Sort By:
Pageof 19
Revue Medicale Suisse|April 8, 2015
[Last generation anti-thrombotic drugs and cerebral hemorrhage ]Pierre Fontana
Revue Medicale Suisse|March 11, 2009
[The new antithrombotics in 2009]Pierre Fontana, Henri Bounameaux
Swiss Medical Weekly|December 7, 2016
Authors' reply to the technical comment from Joelle Michaud and Goranka TanackovicMarc Blondon, Pierre Fontana
Swiss Medical Weekly|July 17, 2019
Authors' reply to the technical comment from Joelle Michaud and Goranka TanackovicMarc Blondon, Pierre Fontana
Polskie Archiwum Medycyny Wewnetrznej|November 6, 2012
Aspirin for venous thromboembolism prevention and treatment: a renewal?Henri Bounameaux, Pierre Fontana
JACC. Cardiovascular Interventions|September 21, 2019
Platelet Function Testing or Genotyping: Which Should We Trust?Pierre Fontana, Jean-Luc Reny
Revue Medicale Suisse|April 5, 2008
[Frequently asked questions on clopidogrel treatment: indications, resistance, and biological evaluation in vascular patients]Pierre Fontana, Jean-Luc Reny
Archives of Internal Medicine|March 12, 2008
Laboratory-defined aspirin resistance and recurrent cardiovascular eventsPierre Fontana, Jean-Luc Reny
Expert Opinion on Pharmacotherapy|December 16, 2014
Antiplatelet drugs and platelet reactivity: is it time to halt clinical research on tailored strategies?Jean-Luc Reny, Pierre Fontana
Revue Medicale Suisse|December 6, 2018
[Antithrombotic treatments and inherited bleeding disorders]ALessandro Casini, Pierre Fontana, Thomas Lecompte
Pageof 19